S.C. Cardiomed S.R.L.
Craiova, Romania
Cardiologist in Craiova
Bloc E3, Bulevardul Nicolae Titulescu, Craiova 200147
About S.C. Cardiomed S.R.L.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Actelion
2
Boehringer Ingelheim
2
Clinical Trials at S.C. Cardiomed S.R.L.
During the past decade, S.C. Cardiomed S.R.L. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
2012-08-22
2019-12-13
Completed
10,471
Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout
2015-08-17
2017-05-10
Completed
196
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
2017-07-11
2021-03-12
Completed
143
A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
2018-12-07
2021-10-12
Terminated
91
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "S.C. Cardiomed S.R.L." #1 sponsor was "Actelion" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials
sponsored, "Amgen" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Cogentus Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "S.C. Cardiomed S.R.L."
#1 collaborator was "AcitGraph" with 1 trials as a collaborator, "Almac Clinical Technologies, LLC" with 1 trials as a collaborator, "Chiltern International Ltd." with 1 trials as a collaborator, "Covance Central Laboratory Services, LP" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at S.C. Cardiomed S.R.L.
According to Clinical.Site data, the most researched conditions in "S.C. Cardiomed S.R.L." are
"Atrial Fibrillation" (2 trials), "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Gout" (1 trials). Many other conditions were trialed in "S.C. Cardiomed S.R.L." in a lesser frequency.
Clinical Trials Intervention Types at S.C. Cardiomed S.R.L.
Most popular intervention types in "S.C. Cardiomed S.R.L." are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Allopurinol 100 up to 600mg/day" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at S.C. Cardiomed S.R.L.
The vast majority of trials in "S.C. Cardiomed S.R.L." are
8 trials for "All" genders.
Clinical Trials Status at S.C. Cardiomed S.R.L.
Currently, there are NaN active trials in "S.C. Cardiomed S.R.L.".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in S.C. Cardiomed S.R.L.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in S.C. Cardiomed S.R.L., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".